Thomas Idorn

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.

Journal: The lancet. Diabetes & endocrinology

Published: January 21, 2026

Response to the letter to the editor entitled "Semaglutide and kidney function: direct kidney protection or an artifact?"

Response to the letter to the editor entitled "Semaglutide and kidney function: direct kidney protection or an artifact?"

Journal: Kidney international

Published: July 11, 2025

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.

Journal: Diabetes care

Published: May 08, 2025

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis.

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis.

Journal: Diabetes care

Published: February 26, 2025

Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial.

Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial.

Journal: Journal of the American College of Cardiology

Published: July 13, 2024

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.

Journal: European heart journal

Published: July 01, 2024

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.

Journal: The New England journal of medicine

Published: May 24, 2024

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.

Journal: Nature medicine

Published: May 17, 2024

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial.

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial.

Journal: Nature medicine

Published: March 25, 2024

Obesity-Related Kidney Disease: Current Understanding and Future Perspectives.

Obesity-Related Kidney Disease: Current Understanding and Future Perspectives.

Journal: Biomedicines

Published: August 11, 2023

Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis.

Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis.

Journal: Pituitary

Published: December 30, 2022

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 29, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026